It was the summer of 2020. Pandemic aside, things were going well for Tuyen Ong, M.D. The physician and biotech entrepreneur ...

American Clinical Research Services has purchased Elixia, a clinical trial network that specializes in studies involving ...

Conversations about clinical trial diversity have finally gone mainstream, but | Sponsors have struggled to improve diversity ...

Johnson & Johnson MedTech’s Biosense Webster division is rolling out a new version of its heart-mapping system that the company says marks its first to employ artificial intelligence capabilities. The ...

Marinus is implementing a raft of cost-cutting measures in the wake of last month's phase 3 struggles—including jettisoning a fifth of its workforce. Employees at the Pennsylvania-based biotech may ...

Accelerated approval—controversial, yes—but absolutely necessary for small, pre-revenue biotechs trying to find new treatments for small patient populations. | Accelerated approval—controversial, ...

Sanofi Chief Scientific Officer and head of research Frank Nestle, M.D., is leaving the company. | Sanofi CSO Frank Nestle is leaving the company, a spokesperson confirmed. He joined the French pharma ...

If your child is in a clinical trial for what could be a groundbreaking treatment to restore hearing, as a parent, you’re going to notice the changes before a clinical investigator ever does. | If ...

Pharming Group has sawed off its gene therapy collaboration with Orchard Therapeutics, a decision that will see the end of a preclinical hereditary angioedema (HAE) program. Netherlands-based Pharming ...

Compass Pathways has navigated to another successful midphase readout, linking its psilocybin therapy and psychological support to improvements in post-traumatic stress disorder (PTSD) in a small ...

A young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy trial has died, the pharma shared in a May 7 ...

Walking Fish Therapeutics has closed after a lead investor backed out of a critical series B round. CEO Rusty Williams, M.D., Ph.D., said in an interview with Fierce Biotech that the company was on ...